Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.

Also called NCT02472028

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 820 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02472028
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT02472028. Randomized; no masking; primary purpose prevention. Start 2015-09 (actual); primary completion 2028-09-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
Acronym
LEOPOLD
Condition
Cerebrovascular Disorders
Intervention (Other)
blood pressure lowering algorithm
Intervention (Other)
usual strategy
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct02472028
Content hash
041f77b0b84bf55e3c7ec6cc99e8d9936f36a651514c299a1d76af93cb05614b